Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

C.M. Huijts; S.J.A.M. Santegoets; A.J.M. van den Eertwegh; L.S. Pijpers; J.B. Haanen; T.D. de Gruijl; H.M.W. Verheul; J.J. van der Vliet

doi:10.1186/1471-2407-11-505

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

C.M. Huijts, S.J.A.M. Santegoets, A.J.M. van den Eertwegh, L.S. Pijpers, J.B. Haanen, T.D. de Gruijl, H.M.W. Verheul, J.J. van der Vliet

Research output: Contribution to journal › Article › Academic › peer-review

89 Downloads (Pure)

Original language	Undefined/Unknown
Article number	505
Journal	BMC Cancer
Volume	11
DOIs	https://doi.org/10.1186/1471-2407-11-505
Publication status	Published - 2011

Access to Document

10.1186/1471-2407-11-505

282669Final published version, 782 KB

Cite this

@article{302227aab68042858e41c791b19edbe9,

title = "Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer",

author = "C.M. Huijts and S.J.A.M. Santegoets and {van den Eertwegh}, A.J.M. and L.S. Pijpers and J.B. Haanen and {de Gruijl}, T.D. and H.M.W. Verheul and {van der Vliet}, J.J.",

year = "2011",

doi = "10.1186/1471-2407-11-505",

language = "Undefined/Unknown",

volume = "11",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central",

}

TY - JOUR

T1 - Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

AU - Huijts, C.M.

AU - Santegoets, S.J.A.M.

AU - van den Eertwegh, A.J.M.

AU - Pijpers, L.S.

AU - Haanen, J.B.

AU - de Gruijl, T.D.

AU - Verheul, H.M.W.

AU - van der Vliet, J.J.

PY - 2011

Y1 - 2011

U2 - 10.1186/1471-2407-11-505

DO - 10.1186/1471-2407-11-505

M3 - Article

C2 - 22129044

VL - 11

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 505

ER -